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The idea, popular among the lai~, that the amenorrhea 
associated with the period of lactation gave protection against 
conception is, of course. known to the medical profession to be 
unfounded. It is obvious to those interested, however, that 
not all women fail to menstruate during lactation and that 
pregnancY does occur in a reasonable number of instances 
either before menses resume or after the qycle has re-established. 
Likewise, the reappearance of menses does not seem to decrease 
or influence the secretion of breast milk, therefore, the endo-
crine s,ystems responsible for lactation and menstruation m~ 
not necessarilY be recipDocal~ related. 
An observation made some years ago and reported in 1943 
b,y Fortune indicates that Arapesh women do not resume menses 
during lactation before the infant has cut its first inCisors, 
although Caucasian women ~ menstruate earlier. These wamen 
are an inbred group (8000 or less) with a characteristic long 
lactogenic interval. Nursing for three years, which is common 
among these women, does not produce amenorrhea for that length 
of time. (1). 
With these simple and gross observations in mind it was 
decided to study the problem of the Nature of the Amenorrhea 
of Lactation in Humans. 
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II REVIEW OF LITERATURE 
A careful review showed theartia~es written on this 
subject to be sparsely distributed throughout the literature. 
Everyone agreed about the growth and development of the 
breast and the process b.r which lactation occurs, but the 
effect of lactation on the menstrual cycle has not been well 
described. 
Novak and Hoskins agree on the theory that at puberty 
the ovarian hormones, estrogen and progesterone, will stimulate 
the anterior pituitary to increase the secretion of a duct 
growth factor (mammogenic hormone). During pregnancy proges-
terone plus estrogen (placental hormones) causes an increased 
secretion of lobule-alveolar growth factor and is responsible 
for proliferation of alveolar ducts and lobules. Theories 
about w~ lactation does not occur during pregnancy are, 1. that 
the placenta produces a lactation suppressing agent, ~. that the 
distended uterus inhibits lactation, 3. that the secretion of 
progesterone b.r the corpus luteum during pregnancy 1nhibits~ 
lactation, 4. that the lactogenic hormone is inadequate during 
pregnancy and is increased 2-4 times within a short time after 
parturition. Novak's only comment about menstruation and ovula-
tion during lactation was to reiterate that OVUlation is followed 
b.Y menstruation if fertilization does not take place, therefore, 
menstruation without ovulation is possible but OVUlation without 
menstruation is impossible unless pregnancy intervenes. 
Hoskins (2) assumes that menstrual failure during lacta-
tion is due to the action of a mammary hormone exerted either 
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directlY on the ovaries or via the anterior-pituitary to 
cause a persist.nce of corpus luteum which in turn arrests 
the cyclic process. It is more probable that the Prolactin 
Hormone is responsible for this. 
One of the most informative papers published was one 
by -Paul Topkins (3) in 1943. His purpose was to deternline 
the extent of ovarian inhibition during lactation. For his 
study he chose to examine the endometrium by biopsy during 
the period of lactation. He assumes that if progestational 
(progesteronal) endometrium is formed, then ovulation has 
taken place and that the absence of such an endometrium indi-
cates, but does not prove, an absence of ovulation, (4). He 
further states that ~lure of OVUlation cannot definite~ be 
established without microscopic study of the ovaries unless 
you aSSUllle ovulation is always followed by lueeinization and 
that luteinization always produces a secretory endometrium. 
Sinee the endometrium usual~ regenerates in three weeks 
post-partum, except at the placental site)where about seven 
weeks is required, Topkins began his biopsies at the 6th post-
partum week. He took 145 specimens from 28-women, eight colored 
and twent,y white, who had had previous regular periods before 
pregnancy and who were otherwise gynecologically normal. Four 
biopsies were taken from each patient and classified as estro-
genic and progestational and the numeer of weeks post-partum 
noted. One hundred thir~ six (136) o. 94% proved to be estro-
genic - and of that 94% - 15~ were poorly developed or ~po-
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estrogenic whereas 85% wer$ fairly well developed and constant 
throughout the amenorrhea, showing mid-follicular phase (end of 
1st week of cycle) endometrium. The remaining 6% showed pro-
gestational endometrium and all were associated with the onset 
of the first menstrual flow. 
Topkins concluded that (l) the endometrium in lactation 
amenorrhea shows diminished estrogen stimulation, (2) during 
lactation the ovarian cycle is suppressed completely in amenorrhea 
and incompletely in lactation menstruation, (3) on the basis of 
animal experimentation, inhibition of ovarian activit,y is the 
result of suppression of gonad atrophic activity of the hypophy-
sis and that (4) suppression of gonadatrophic activit,y, in turn, 
is due to the action of prolactin or else to a hormone of the 
lactating mammary gland not yet isolated. 
He suggests that 85% of cases of undifferentiated endo-
metrium,as in the first week of the cycle, indicates that the 
follicle is not fully developed and that 15% of cases with bypo-
plasia suggest that those follicles are regressing. This study 
indicates that in lactation amenorrhea there is inhibition of 
ovarian activity, the follicles failing to mature to the point 
of rupture. Topkins also further concludes tr~t it is reason-
able to assume if luteinizing hormone is responsible for lacta-
tion amenorrhea then ovulation would be present, which it is not. 
We now know, however, that pure Follicle Stimulating Hormone 
will stimulclte the ovarian follicle to the point of morphological 
development but does not cause the secretion of estrogen. 
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The addition of Luteinizing Hormone (L.H.) is necessary to 
produce estrogen and for rupture of follicles to occur, (5). 
Another careful study is reported by Cherry (6), who ill 
19a5-37 described the action of the mammary gland on the ovary. 
His paper states that the mammary gland develops under the in-
fluence of estrogen and when prlmed by the corpus luteum hor-
mone the administration of estrogen wiLl stimulate lobular-
alveolar development. During pregnancy estrogen is present in 
large amounts in the Circulation, reaching a peak shortly be-
fore parturition and falling marked~ after parturition. This 
fall in estrogen releases the inhibitory action on the pituitary 
gland and prolactin or lactogenic hormone is released under the 
sucking reflex stimulus, which is a function of the bypothalmus. 
Cherry then explains the lack of menstruation in a majority of 
women during lactation on the basis that there is a low estrogen 
level in the circulation that is inhibited by some antagonistic 
hormone action, from the lactating breast, prevent:i.ng the matura-
tion of the ovarian follicle. This action,he thinks~varies in 
intensity and it is assumed that when ovulation j menstruation 
or pregnancy do occur during lactation that the pituitary has 
overcome this inhib~Ltion. Cherry, too, assumes the ovari~ 
failure is probablY secondary to pituitary suppression. Cherry's 
investigation was based on a theory that the breast produced a 
substance at tlle beginning of lactation which inhibited matura-
tion of the ovarian follicle and ovulation. He injected alcohol 
precipitates of pregnancy urine and extracts of lactating mammary 
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gland into albino rats. In the gonadatrophic injected controls 
corpora hemorrhagica and corpora lutea developed in every in-
stance. In the controls injected with extracts of mammary gland 
no change was noted either macroscopically or microscopically. 
When the two extracts were mixed in the same s-,fringe and given 
together the result in most instances was complete absence of 
corpora hemorrhagica ~d corpora lutea. Follicular development 
was present in the majority of instances, but in some animals 
this too was absent) as confirmed b.Y negative vaginal smears and 
microscopic sections. 
FUrther work on the rabbit proved there was a definite 
inhibitory action of the lactating mammary gland on the ovary. 
Griffith and McBride (7) in 1939 reported 21-post par tum 
patients examined and biopsied at intervals varying from three 
to twenty-four weeks. Ten patients nursed their babies from 
two to nine months and eight of these, 80%, began to have men-
strual periods and ovulation only after weaning. The average 
duration of nursing was 3~-months, followed by anovulatory flow 
at five months and qy the first ovulation at 5;-months. Two 
patients, 20%, had regular menses (Ovulatory) during their 
period of lactation. One of these had menstrual periods begin-
ning after two months, ovulation after five months. She nursed 
her child seven months. Another had menstrual periods ri-
established after six months, OVUlation after 6·~-months. She 
weaned her child at age nine months. 
Eleven patients unable to nurse babies had menstrual 
periods beginning on an average of two months post-partum and 
OVUlation at five months post-partum or later. 
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In 95% of these cases an anovulatory flow preceded ovulation. 
These authors assume~as does Topkins~that Pituitary Gonadatrophin 
is immediately suppressed~probably due to the lactogenic hormone 
or some other uWol0wn internal secretion. 
Furtller studies along the same theme done by Kurzrok, Lass 
and Smelser (8) consisted of biopsies done on thirty women who 
were simultaneously lactating and having regular menstrual cycles. 
They establish in their series that 65% of these cycles are sterile 
or anovulatory periods. A year later(9), in 1938, these same 
authors presented another study relating to the time of human 
ovulation dur~g lactation, in which they again biopsied post-
partum women who were nursing regularly and having regular cata-
menia. The presence of secretory endometrium indicates ovulation 
and the presence of non-secretory endometrium within ten days of 
the succeeding menstrual flow indicates an anovulatory cycle in 
their series. Forty-seven women were studied by biopsy at four 
week intervals and 55% of these cycles were anovulatory and 45% 
were ovulatory. 
Pregnandiol output in the urine is now accepted as an index 
of corpus luteum activit¥ in both the pregnant and non-pregnant 
woman. Fifty-one cases of pregnandiol excretion were studied 
during the first post-partum week by Wilson, Randall and Osterbery 
showing evidence that some pregnandiol is present immediately 
after parturition but in amounts less than those found ante-
partum (10). Estimates of pregnandiol on the 4th post-partum 
day showed 45% negative, 21% minimal and 34% with a mean value 
of 2.75 to 6-mgms per 24-hours. This may indicate some corpus 
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luteum function post-partum and its association with lactation 
is not yet known. 
Robinson (11) discusses the subject from the opposite 
point of view, namely: if menstrual periods are resumed or if 
pregnancy does occur during lactation does milk secretion stop? 
He interviewed over 600 mothers regarding the age of weaning and 
the time their menstrual periods resumed. He concluded that men-
struation is neither a reason for weaning nor a cause for failure 
of lactation; these functions seem to be independent of lactation. 
In the series of women pregnant and simultaneously lactating, 
maqy pregnancies went unnoticed until foetal movements were felt. 
EV this time the foetus is 18-20 weeks old and the nursing in-
fant seven months old which means that adequate lactation had 
continued for five months of pregnancy. ~ seven months lacta-
tion normally diminishes so the lowered output after that could 
not be attributed to the pregnancy. 
Other work based on arumal experimentation has been pub-
lished and where possible has been applied in theory to humans. 
Bates, Lahr and Riddle (12) in 1935 showed that data concerning 
the action of F.S.H. and prolactin on the ovary and sex accesso-
ries of fowls fell into two contrasting groups demonstrating 
directly opposite effects. Prolactin stopped ova production and 
caused decrease in ovarian weight. F.S.H. stimulated ova pro-
duction, stopped laying and increased ovarian weight markedly. 
Prolaotin decreased oviduota1 and uterine Size, comb size and 
pubic bone width, whereas F.S.H. increased the size of these 
structures. 
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Lahr and Riddle (12) injected Prolactin into non-lactating 
rats and observed suspension of two to four estrous cycles 
with large undegenerated corpora lutea in the ovaries. Pro-
gesterone produced no such effect. Riddle and Bates (13) in 
1933 showed prolactin to cause regression in the weight of 
the testis of a pigeon and concluded the same to be true of 
the ovary. The.y therefore offer the possibility that the gonad-
stimulating (sex-maturing) hormone is heM in abeyance by cir-
culating prolactin. Turner and Meitus (14-15) showed that in 
rabbits the lactogenic hormone which was low during pregnancy 
increased 2 - 4 times after parturition and this increase was 
not influenced by a simultaneous pregnancy. FinalJ.¥ in 1934 
Collip, Sel3'e and Thomson (l6~ presented the idea that the 
stimulus of sucking was also involved in this problem via the 
~pothalmus. They believe suckling stimulates the anterior-
pituitary to produce prolactin and to mOdifY its activity 
toward the ovary so that corpora lutea 09 post-partum OVUlation 
long retain their healthy structure and active function while 
further ovulation and phenomena of estrus are inhibited. 
From these articles it is evident that much is still to 
be learned about the pqysiological actions of these endocrine 
glands during lactation. 
Further light was shed on the subject by Albright, Smith 
and Dodge (17) when in their presentation of a new method of 
ass~ of pituitary F.S.H. they review a case of secondary 
amenorrhea with perSistent lactation after 2i-years. The F.S.H. 
output per-24-hours in this patient fell within the normal 
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limits instead of being suppressed and the,y promised a fur-
ther investigation of the problem of lactation amenorrhea. 
III PURPOBE 
The idea that the F.S.H. output per 24-hours may con-
sistently be within normal limits is the basis for the fol-
lowing investigation. The hormone level will be determined 
b.Y urinary assay and correlated with the simUltaneous endo-
metrial biops.y findings in an attempt to not only confirm 
other work done on the inoidence of ovulation during lacta-
tion but also to determine the true status of the pituitary 
activity • 
IV EXPERIMENTAL PROCEDURE 
Thirteen colored females were selected from the Post-
Partum Clinio at the Louisville General Hospital at the time 
of their regular six weeks post-partum examination. These 
women were biopsied and an assay of urinary F.B.H. was taken 
simultaneously. All of the patients were in good general 
health and had had no previous menstrual irregularities. These 
women were examined at various intervals between their 6th and 
19th post-partum week. The incidence of non-secretory and secre-
tory endometrium was observed; the level of Pituitary F.B.H. 
output per 24-hours was determined and the presence or absence 
of menstruation was noted during their period of lactation • 
The data is compiled in charts and is here discussed. One case 
of persistent amenorrhea in a patient l4-months post-partum 
is presented. 
Discussion regarding the method of hormone assay is needed. 
The procedure used is that described and confirmed b,y Smith, 
Albright and Dodge, (17-18), in 1943. An eight hour overnight 
urine specimen is filtered and if necessary acidified with 
acetic 
g~acia~acid. One gram of sodium chloride per 100 cc of urine 
is added and four volumes of 95% etny~ alcohol. This is cooled 
overnight in the refrigerator and the precipitate collected in 
a 250 cc centrifuge bottle. The precipitate is washed with anhy-
drous ether and dried overnight in a vacuum dessicator. The pre-
cipitate is then redissolved in water, 30-45 cc, and dialysized 
for four hours against running tap water DO remove impurities 
and render the specimen less toxic. The product of dialysis is 
re-precipitated b,y adding .1 gm NaC~ to the who~e specimen 
(45-cc) and f:.:>ur volumes of ethyl alcohol. This is cooled over-
night and the precipitate collected in a 50 cc centrifuge tube 
and again dried with anhydruus ether overnight in a dessicator. 
This precipitate 1s stable at room temper~ture and when ready 
for use is dissolved in 5.5 cc of distilled water and kept re-
frigerated until the assay is completed. White mice 19 to 20 
days old and weighing 7-10 gms are used for the assay and are 
injected subcutaneously in the back with 2;1-cc of test solution 
over a period of three days, receiving ~ cc at each injection. 
Twant,y-four hours after the last injection the mouse is autopsied 
and the uterine weight determined by removing it, pressing it 
between filter paper to remove the exc&ss tissue fluid and 
weighing it on a balance. 
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One mouse unit ot hormone is the amount required to 
produce 100-150% increase in the size of the uterus (weight). 
NorInalIy the uterus in animals injected with saline as con-
trols weighed 3.7 mgs I or - .9 mgms as reported b.1 Albright, 
et ale In this series, and with this particular strain of 
mice, 14 animals kept as controls had an average uterine weight 
of 3.28 mgm. The final precipitate contains all the hormone 
excreted b.Y that patient in an eight hour period, therefore it 
2.5 cc of this 5.5 cc solution contains one or more Mouse Units 
(Mu) as indicated b,y a positive test, then the 5.5 cc will con-
tain 2.2 Mu. The patient's output for 24-hours would then be 
6.6 Mu. ~ making appropriate dilutions with water the original 
specimen may be further ass~ed for higher levels of F.S.H. 
The level for normal regularly menstruating women, not 
pregnant and not lactating, is more than 6.6 and less than 53 Mu 
units in 24-hours, according to standards reported b,y Albright, 
Smith and Dodge. These authors stress the importance ot the 
F.S.H. test, in that at present it is the only anterior pituitary 
hormone that can be ass~ed easily and also suggest tl~t it be 
applied further clinically. The procedure is simple in technique, 
its main fault being the amount of time required to prepare one 
specimen for ass~ (44-92 hours) - (5). 
Regarding the use of the alcohol precipitate test, Heller 
and Heller (19) cite five advantages of this method over other 
extractions, chiefly the tannic acid or tungstic acid precipi-
tates. It is simple and direct, the products are stable for 
storage at aqy stage, the F.S.H. is concentrated ma~ times, 
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dialysis removes a large percentage of the toxicit.y (probably 
b.1 removal of salts), potency is not affected b,y detoxification, 
Just as large or larger amounts of hormone are recovered with 
this method. The use of the mouse uterus as the endpoint for 
the assay was established b.1 Levin and T,yndale (20). This 
proved to be a more accurate and more sensitive test than did 
follicular enlargement, increase in ovarian weight or vaginal 
canalization. These authors established the absence of estro-
genic sUbstances in the urine by injections into spayed rats as 
well as by the fact that all potency was destri.Jyed by heating, 
acid treatment and other procedures which would not injure 
estrin~had it been present. The uterine response was 67% 
greater if mice were autopsied 72-hours after the first in -
jection. 
The endometrial biopsies were made with a Novak curette, 
after cleansing the cervix with Merthiolate. The tissue ob-
tained was fixed with Formalin (10%), sectioned and stained 
with H &'E. as a routine procedure of this clinic. Classifica-
tion as to secretory or non-secretory activit,y is made on the 
basis of the standard text books of Qynecology (Novak). 
A. Acidified Filtered Urine with Alcohol Added. 
B. First Precipitate. 
C. Dialysis Process. 
D. Dialysized Specimen with Alcohol Added. 
E. Second Precipitate. 
F. NaCl & Balance. 
A. Biopsies - sections. 
~. Index File. 
C. Mouse board - lco syringe - Specimen Bottles. 
D. Usual t,ype breeding pan. 
E. Autopsied mice. 
V LACTATION.AMENORRHEA. DATA 
PATIENT HISTORY ------:-- ---mopgy--- -~------F.S-:I!0¥UJ----- ---CCMtlENT WKS. PQST"PARTUM 
I L.A. Para iii (3/3/47). 
Did not menstruate 
24-yr. C.F. with prev. lact. 








~6.6 -26 -53 Lactating. 
19.8mg. 4.4 mg. 4.4 mg. No menses. 
~6.6 ~26 ~53 Lactating. 
79 mg. 38.2mg. 51 mg. No menses. 
33.lmg. 26.3mg. 
~6.6 -26 -53 Lactating 
29.3 mg. 6.1 mg. 5.5mg. No menses. 
~6.6 ~26 -53 Lactating. 
69.2mg. 21mgs. 6.5mg. r~o menses. 
6/30/47-Tnt. non-sec. ~6.6 -26 -53 L.M.P. 6/13 - 17fo47. 
2. M.E.B. 
24-yr. C.F. 
Para iii 0/2/47). 4!11/47-Int. Non-sec. 
L.M.P. 3-days beg. (s1. hyperplasia). 
4/11/47. No cramp. 





1-6.6 1-26 -53 Bleeding 3-days beg. 
32.lmg. 15~2mg. 5.2mg. 4/11/41. 
~6.6 ~26 -53 Lactating. 
66 mg. 19.1mg. 5.1 mg. 
~6.6 -26 -53 
10.7 mg. 3mg. 
~6.6 -26 
12.8 mg. 5mg. 
Scant bleeding 1~ 
days beg. 5/11/47. 
Lactating. 
L.ll.P. 6/17/47. 












PATIENT HI8TORY- -- BIOPSY-· -- F.8.H.~MU:J . COMMENT WKS :POST4PARTUM 
3. L.B. Para i (2/20/47). 414147-Int. non.sec. 1-6.6 -53 Lactating. 6 
Lactating. 81. hyperplasia. 8.4 mg. 3.5 mg. 
27-yr. C.F. No menses. 
4118/47-Int.nonsec. -6.6 -6.6 Lactat:ing. 8 
(Thrombosis) 6.4 mg. 3.5mg. 
5/2/41-Int.non-sec. 1-6.6 -26 -53 Lactat:ing. 10 
2lmg. 4.5mg. 4.3mg. No menses. 
5/16/47-Int. non-sec. 1-6.6 -26 -53 Lactating. 12 
49.3mg. 3.3mg. 3.3mg. No menses. 
U. E.B. Para vi (2/6/47). 4111/47-Int. non-sec. 1-6.6 1-26 -53 Lactating. 9 
Lact. No menses. 40.8mg. 12.2mg. 5.J.ul1g. 
29-yr. C.F. Did mens. during 
prevo lact. Did 4125/47-Int. non-sec. 1-6.6 -26 -S3 Lactating. 11 
become pregnant 24.L1I1g. 5.2mg. 4.8mg. No menses. 
dur:ing a previous k.3mg. 
lactation. 5/9/47-Int. non-sec. -6.6 -6.6 Lactating. 13 
5.1mg. 3.0 mg. No menses. 
5/23/47-Int. non-sec. 1-6.6 -26 -53 Lactating. 15 
9.2mg. 3.0mg. 3.2mg. No menses. 
5. R.C. Para i (2/16/47) 4.I4147-Int. non-sec. 1-6.6 1-26 -53 7 
Lactating. 30.6rng. 20mB. 5.6mg. 
16-yr. C.F. No menses. 
4118/47-Int. non-sec. 1-6.6 1-26 -53 Lactating. 9 









Para U (1/25/47) 
Lactating. No mens. 
No mens. during 
prev. lactation. 
Para iT 0/8/47) 
8. N.M. Para ii (3/12/47) 
Lact. No mens. 
27-yr. C.F. No mens. or preg. 
dur. pre v • lact. 
9. P.R. Para Ui 0/6/47) 
Lact. No mens. 
31-yr. C.F. No.mens. or preg. 
during prev.lact. 
!V25/47-Int. non-sec. 




~6.6 ~26 -53 
27.7mg. 10.5mg.4.6mg. 
Nursed 1st baby 
9-mos. Mens. 
@ 13-mos. 
~6.6 ~26 -26 -53 Lactating. 
33mg. 12mg. 3mg.3mg.3mg.No mens. 
~.6 ';'~6 -53 Lactating. 
28.4mg. 20 ,,6mg. 4.lmg. No menses. 
~6.6 ~26 
22 mg. 11mg. 
-53 Lactating. 
4.3mg. No menses. 
4!24/47-Int. Hon-sec. ~6.6 
(Atrop~ of stroma) 
-26 -53 Lactating. 
Irregular spotting. 
5/9/41-Int. non-sec. ~6.6 -26 -53 
36mg. 31Omg. 3.0mg. 3.0mg. 
5/23/47-Int. non-3ec. ~6.6 ~26 -53 Lact. Exam shows 
19.8mg. 9.1mg. 5.2mg normal mens. flow. 
6/27/47-Int. non-sec. ~6.6 -26 -53 L.M.P. 5/23/47. 
5/9/47-Int. non-sec. Specimen Toxic. 
Mice died. 
One day. Lactating. 
No period in June. 
Pds. resumed I-mo. 
after lact. stopped 












10. E.K. Para v 0/5/47) 
14-mos. post.-part. 
30-yr. C.F. no mens. Nursed 
other babies 6-
mos. Did not mens. 
dur. lact. Resumed 
Catamenia 3-mos af-
ter 'Weaning. 
11. M.D. Para 11 (4/4/47) 
Lact. No mens. 
21:"yr. C.F. Did not nurse 1st. 
baby. Catamenia 
resumed @ 2~mos. 
post-partum. 
12. C.G. Para 1 (4/5/47) 
Lactat:ing. 
IS-yr. C.F. No mens. 
13. M.W. Para 1 (4/10/47) 
Lact. No mens. 
20-yr. C.F. 
BIOPSY F.s.H.~1 COMMENT WKS.POST-PARTUM 
5/20/47-Int. non-sec. 14;6 1-26 -53 Lactating. 62 
Atrophy of endometrium. 35.3mg.10.3mg. 3.0 mg. Breasts congested. 
6/30/47-Int. non-sec. 1-6.6 1-26 -53 No menses. 
Not lactating. 












5/23/47-Late Int. Sec. 1-6.6 
35 mg. 
-26 -53 (Should mens.within 






1-26 -53 L.M.P. l!-days beg. 
l2.2mg. 4.lmg. 5/24/47. Abscess of 
breast rupt. sponte 
Rx Stilbesterol 5-mg. 
















The data in the preceding chart m~ be tabulated somewhat 
as follows: 
Thir~-four F.S.H. determinations on 13 patients were 
done and 36-biopsies are reported. Two F.S.H. speci-
mens were toxic and the mice assayed with these samples 
died before receiving the final injection. 
The incidence of non-secretory endometrium was 97% 
(35 biopsies). The corresponding F.S.H. ass~s showed; 13 
specimens positive for 6.6 Mu and negative for 26 Mu, and 17 
specimens positive for 26 Mu but negative for 53 Mu, giving 
a total of 30 F.S.H. specimens well within the normal limits 
of daily output for regularly menstruating, non-pregnant, non-
lactating women. The incidence of normal F.S.H. in percent in 
this series is therefore 91%. Two F.S.H. levels (6%) were less 
than 6.6 Mu per 24-hours and these were associB.ted with a non-
secretory endometrium. One F.S.H. level (3%) was above 53 Mu 
but below 85 Mu per 24-hours and this was associated with a non-
secretory endometrium. All three patients showing other than 
nornml F.S.H. levels on one occasion had at least 3 or 4 other 
ass~s with the normal levels. 
One biopsy of late interval secretory endometrium was 
obtained, the incidence being 3% (case 13). This was associated 
with a normal F.S.H. level (more than 6.6 Mu, less than 26 Mu 
per 24-hours) and the patient had a scan~ menstrual period 
which began about 36-hours after the biops,y was taken. 
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Four patients (30.7%) had catamenia resumed during 
this period of observation and o:f these, three were anovula-
tory and. one ovulatory in nature (case 1,2,8, & 13). Nine 
cases (69.3$) were complete amenorrheas throughout the period 
of observation. 
One patient with a breast abscess is interesting in that 
at six weeks post-partum a biopsy of secretory endometrium was 
obtained, and the patient t~d a scan~ menstrual period begin-
ning l!-days later. At 9 weeks the patient was seen again, at 
which time she had a breast abscess which had ruptured spon-
taneousl¥ • The endometrium on that day was non-secretory. The 
local breast lesion was treated and the patient given 5 mgm. of 
Sti~besterol dail¥ for 5 days to dry up her breasts, and the 
bab.Y weaned. At ten weeks post-partum (one month after the 
secretory biopsy) this patient showed a non-secretory endome-
trium and four days later had a scanty 3-day menstrual period. 
At 11 weeks post-partum the patient had a non-secretor,y endome-
trium. It is suggested that this patient's second menstrual 
c.ycle was anovulator,y in nature and that the dose of Stilbesterol 
given to control lactation from the breasts was also sufficient 
to inhibit oVUlation in that cycle. All F.S.H. assays on the 
patient were normal. 
One case of perSistent amenorrhea at 14-months post-partum 
is presented (case 10). This patient had two endometrial biopsies, 
both of which were non-secretory, the first being ver,y atrophic. 
Both F.H.S. assays were within normal levels (more than 26 Mu 
and less than 53 Mu per 24-hours). 
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Vl DISCUSSION 
In discussing this problem and the above data it is 
necessary to consider the reclassification of the amenorrheas 
in the light of our knowledge of F.S.H. which was presented b,y 
,Albright. There may be primary ovarian failure with ~po­
estrinism as in the case of menopause patients. In this group 
F.S.H. is increased in the urine. There may be secondar,y 
ovarian failure with ~poestrin1sm due to pituitary gonad-
atrophin failure. In this group F.S.H. is decreased in the 
urine~ i.e.~ Simmondfs cachexia. A third group is now es-
tablished in which there is hypoestrinism with ovarian failure 
associated with a normal F.S.H. output. There is a psychic 
factor present in this third group which cannot be overlooked~ 
and it is conceivable that the hypothalamus is responsible in 
this group for the release of some precursor of estrin via the 
hypothalamic-pitultar,y pathway which is non-estrogenic and which 
is inhibitory to F.S.H. In a~ case the level of F.S.H. in this 
class of hypothalamic amenorrheas .is normal. 
In animals it is established that coitus with subsequent 
nervous impulses is responsible via the hypothalamic-pituitary 
tract tor the release of luteinizing hormone (LH) necessary tor 
ovu1ation but whether this is directlY applicable to humans is 
not known. We do know that F.S.H. causes ripening of ovarian 
follicles, that F.S.H. plus L.H. causes the follicle to produce 
estrin and to cause 
-fovulation~ that L.H. causes corpus luteum formation and that 
L.H. plus luteotropin causes the corpus luteum to produce 
progesterone (17). 
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It then becomes evident to suspect that amenorrhea 
associated with a normal F.S.H. output may be the result Qf 
dysfunction of the hwpothalamic-pituitary nervous pathway 
governing the release of prolactin and L.H. 
The predominance of a non-secretory endometrium in con-
trast to a secretory endometrium may indicate an absence of a 
functioning corpus luteum as previous~ speculated. The inci-
dence of non-secretory and secretory endometrium in this series 
is consistent with that found b.1 Topkins in a larger series. 
The incidence of a normal F.S.H. in over 90% of specimens 
would indicate that this factor of the anterior pituitary is 
not suppressed during lactation and that lack of ovulation and 
menstruation cannot be explained on the basis of lack of follicu-
lar maturation. 
This finding is consistent with the unpublished data 
supplied Qy Dr. Anne Forbes concerning 9 assays of F.S.H. done 
on lactating women in Dr. Fuller Albright's laboratory. All 




From this study the only conclusions Justified are: 
1. that the anterior-p1tuitary gland output of F.S.H. during 
lactation is normal in 90% of cases; 2. that there is no 
relation between this level of F.S.H. and the incidence of 
menstruation or ovulation during lactation; 3. that the 
amenorrhea of lactation is not due to failure of the follicle 
to receive its growth stimulus. 
It may be Justifiable to suppose that the amenorrhea of 
lactation may be due to a lack of L.H. or luteotropin and that 
a~pothalamic-pituitar.y nervous mechanism may be responsible 
for this. 
Vlll SUMMARY 
The problem of the amenorrhea associated with lactation 
is presented, the literature reviewed and the incidence of 
catamenia discussed. Thirteen cases of lactation amenorrhea, 
complete and incomplete, are studied and reports of 36 endo-
metrial biopsies and 34 F.S.H. ass~s are given. The incidence 
of non~secretor,y endometrium is found to be 97%, of secretDr,y 
endometrium 3%. The incidence of normal daily levels of F.S.H. 
is 91%. Six~-nine percent mf patients were complete amenorrheas 
and 31% had catamenia re-establ1shed during the period of obser-
vation. The significance of the observations are considered and 
it is concluded that the amenorrhea of lactation is not due to 
suppression of the anterior p1tuitar,y i'o~licle stimulating 
factor. 
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